Table of Content

1 Study Coverage
1.1 Rabies Immune Globulin (Human) Product Introduction
1.2 Market by Type
1.2.1 Global Rabies Immune Globulin (Human) Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 HyperRAB S/D
1.2.3 KEDRAB
1.3 Market by Application
1.3.1 Global Rabies Immune Globulin (Human) Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Clinic
1.3.3 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rabies Immune Globulin (Human) Sales Estimates and Forecasts 2024-2034
2.2 Global Rabies Immune Globulin (Human) Revenue by Region
2.2.1 Global Rabies Immune Globulin (Human) Revenue by Region: 2024 VS 2022 VS 2034
2.2.2 Global Rabies Immune Globulin (Human) Revenue by Region (2024-2024)
2.2.3 Global Rabies Immune Globulin (Human) Revenue by Region (2024-2034)
2.2.4 Global Rabies Immune Globulin (Human) Revenue Market Share by Region (2024-2034)
2.3 Global Rabies Immune Globulin (Human) Sales Estimates and Forecasts 2024-2034
2.4 Global Rabies Immune Globulin (Human) Sales by Region
2.4.1 Global Rabies Immune Globulin (Human) Sales by Region: 2024 VS 2022 VS 2034
2.4.2 Global Rabies Immune Globulin (Human) Sales by Region (2024-2024)
2.4.3 Global Rabies Immune Globulin (Human) Sales by Region (2024-2034)
2.4.4 Global Rabies Immune Globulin (Human) Sales Market Share by Region (2024-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rabies Immune Globulin (Human) Sales by Manufacturers
3.1.1 Global Rabies Immune Globulin (Human) Sales by Manufacturers (2024-2024)
3.1.2 Global Rabies Immune Globulin (Human) Sales Market Share by Manufacturers (2024-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rabies Immune Globulin (Human) in 2022
3.2 Global Rabies Immune Globulin (Human) Revenue by Manufacturers
3.2.1 Global Rabies Immune Globulin (Human) Revenue by Manufacturers (2024-2024)
3.2.2 Global Rabies Immune Globulin (Human) Revenue Market Share by Manufacturers (2024-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rabies Immune Globulin (Human) Revenue in 2022
3.3 Global Key Players of Rabies Immune Globulin (Human), Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Rabies Immune Globulin (Human) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rabies Immune Globulin (Human), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rabies Immune Globulin (Human), Product Offered and Application
3.8 Global Key Manufacturers of Rabies Immune Globulin (Human), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rabies Immune Globulin (Human) Sales by Type
4.1.1 Global Rabies Immune Globulin (Human) Historical Sales by Type (2024-2024)
4.1.2 Global Rabies Immune Globulin (Human) Forecasted Sales by Type (2024-2034)
4.1.3 Global Rabies Immune Globulin (Human) Sales Market Share by Type (2024-2034)
4.2 Global Rabies Immune Globulin (Human) Revenue by Type
4.2.1 Global Rabies Immune Globulin (Human) Historical Revenue by Type (2024-2024)
4.2.2 Global Rabies Immune Globulin (Human) Forecasted Revenue by Type (2024-2034)
4.2.3 Global Rabies Immune Globulin (Human) Revenue Market Share by Type (2024-2034)
4.3 Global Rabies Immune Globulin (Human) Price by Type
4.3.1 Global Rabies Immune Globulin (Human) Price by Type (2024-2024)
4.3.2 Global Rabies Immune Globulin (Human) Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Rabies Immune Globulin (Human) Sales by Application
5.1.1 Global Rabies Immune Globulin (Human) Historical Sales by Application (2024-2024)
5.1.2 Global Rabies Immune Globulin (Human) Forecasted Sales by Application (2024-2034)
5.1.3 Global Rabies Immune Globulin (Human) Sales Market Share by Application (2024-2034)
5.2 Global Rabies Immune Globulin (Human) Revenue by Application
5.2.1 Global Rabies Immune Globulin (Human) Historical Revenue by Application (2024-2024)
5.2.2 Global Rabies Immune Globulin (Human) Forecasted Revenue by Application (2024-2034)
5.2.3 Global Rabies Immune Globulin (Human) Revenue Market Share by Application (2024-2034)
5.3 Global Rabies Immune Globulin (Human) Price by Application
5.3.1 Global Rabies Immune Globulin (Human) Price by Application (2024-2024)
5.3.2 Global Rabies Immune Globulin (Human) Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Rabies Immune Globulin (Human) Market Size by Type
6.1.1 US & Canada Rabies Immune Globulin (Human) Sales by Type (2024-2034)
6.1.2 US & Canada Rabies Immune Globulin (Human) Revenue by Type (2024-2034)
6.2 US & Canada Rabies Immune Globulin (Human) Market Size by Application
6.2.1 US & Canada Rabies Immune Globulin (Human) Sales by Application (2024-2034)
6.2.2 US & Canada Rabies Immune Globulin (Human) Revenue by Application (2024-2034)
6.3 US & Canada Rabies Immune Globulin (Human) Market Size by Country
6.3.1 US & Canada Rabies Immune Globulin (Human) Revenue by Country: 2024 VS 2022 VS 2034
6.3.2 US & Canada Rabies Immune Globulin (Human) Sales by Country (2024-2034)
6.3.3 US & Canada Rabies Immune Globulin (Human) Revenue by Country (2024-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rabies Immune Globulin (Human) Market Size by Type
7.1.1 Europe Rabies Immune Globulin (Human) Sales by Type (2024-2034)
7.1.2 Europe Rabies Immune Globulin (Human) Revenue by Type (2024-2034)
7.2 Europe Rabies Immune Globulin (Human) Market Size by Application
7.2.1 Europe Rabies Immune Globulin (Human) Sales by Application (2024-2034)
7.2.2 Europe Rabies Immune Globulin (Human) Revenue by Application (2024-2034)
7.3 Europe Rabies Immune Globulin (Human) Market Size by Country
7.3.1 Europe Rabies Immune Globulin (Human) Revenue by Country: 2024 VS 2022 VS 2034
7.3.2 Europe Rabies Immune Globulin (Human) Sales by Country (2024-2034)
7.3.3 Europe Rabies Immune Globulin (Human) Revenue by Country (2024-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rabies Immune Globulin (Human) Market Size
8.1.1 China Rabies Immune Globulin (Human) Sales (2024-2034)
8.1.2 China Rabies Immune Globulin (Human) Revenue (2024-2034)
8.2 China Rabies Immune Globulin (Human) Market Size by Application
8.2.1 China Rabies Immune Globulin (Human) Sales by Application (2024-2034)
8.2.2 China Rabies Immune Globulin (Human) Revenue by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia Rabies Immune Globulin (Human) Market Size by Type
9.1.1 Asia Rabies Immune Globulin (Human) Sales by Type (2024-2034)
9.1.2 Asia Rabies Immune Globulin (Human) Revenue by Type (2024-2034)
9.2 Asia Rabies Immune Globulin (Human) Market Size by Application
9.2.1 Asia Rabies Immune Globulin (Human) Sales by Application (2024-2034)
9.2.2 Asia Rabies Immune Globulin (Human) Revenue by Application (2024-2034)
9.3 Asia Rabies Immune Globulin (Human) Sales by Region
9.3.1 Asia Rabies Immune Globulin (Human) Revenue by Region: 2024 VS 2022 VS 2034
9.3.2 Asia Rabies Immune Globulin (Human) Revenue by Region (2024-2034)
9.3.3 Asia Rabies Immune Globulin (Human) Sales by Region (2024-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Market Size by Type
10.1.1 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Type (2024-2034)
10.1.2 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Type (2024-2034)
10.2 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Market Size by Application
10.2.1 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Application (2024-2034)
10.2.2 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Application (2024-2034)
10.3 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Country
10.3.1 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Country: 2024 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Country (2024-2034)
10.3.3 Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Country (2024-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.1.4 CSL Behring Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.2.4 Grifols Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.3.4 Sanofi Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Kamada
11.4.1 Kamada Company Information
11.4.2 Kamada Overview
11.4.3 Kamada Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.4.4 Kamada Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kamada Recent Developments
11.5 Bharat Serum
11.5.1 Bharat Serum Company Information
11.5.2 Bharat Serum Overview
11.5.3 Bharat Serum Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.5.4 Bharat Serum Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bharat Serum Recent Developments
11.6 Bio Products Laboratory
11.6.1 Bio Products Laboratory Company Information
11.6.2 Bio Products Laboratory Overview
11.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.6.4 Bio Products Laboratory Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bio Products Laboratory Recent Developments
11.7 Shanghai RAAS
11.7.1 Shanghai RAAS Company Information
11.7.2 Shanghai RAAS Overview
11.7.3 Shanghai RAAS Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.7.4 Shanghai RAAS Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai RAAS Recent Developments
11.8 Weiguang Bio
11.8.1 Weiguang Bio Company Information
11.8.2 Weiguang Bio Overview
11.8.3 Weiguang Bio Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.8.4 Weiguang Bio Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Weiguang Bio Recent Developments
11.9 Shuanglin Bio
11.9.1 Shuanglin Bio Company Information
11.9.2 Shuanglin Bio Overview
11.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.9.4 Shuanglin Bio Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shuanglin Bio Recent Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Overview
11.10.3 CBPO Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.10.4 CBPO Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CBPO Recent Developments
11.11 CNBG
11.11.1 CNBG Company Information
11.11.2 CNBG Overview
11.11.3 CNBG Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.11.4 CNBG Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CNBG Recent Developments
11.12 Sichuan Yuanda Shuyang
11.12.1 Sichuan Yuanda Shuyang Company Information
11.12.2 Sichuan Yuanda Shuyang Overview
11.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.12.4 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sichuan Yuanda Shuyang Recent Developments
11.13 Kedrion Biopharma
11.13.1 Kedrion Biopharma Company Information
11.13.2 Kedrion Biopharma Overview
11.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.13.4 Kedrion Biopharma Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Kedrion Biopharma Recent Developments
11.14 Congruent Pharmachem
11.14.1 Congruent Pharmachem Company Information
11.14.2 Congruent Pharmachem Overview
11.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.14.4 Congruent Pharmachem Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Congruent Pharmachem Recent Developments
11.15 hualanbio
11.15.1 hualanbio Company Information
11.15.2 hualanbio Overview
11.15.3 hualanbio Rabies Immune Globulin (Human) Sales, Price, Revenue and Gross Margin (2024-2024)
11.15.4 hualanbio Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 hualanbio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rabies Immune Globulin (Human) Industry Chain Analysis
12.2 Rabies Immune Globulin (Human) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rabies Immune Globulin (Human) Production Mode & Process
12.4 Rabies Immune Globulin (Human) Sales and Marketing
12.4.1 Rabies Immune Globulin (Human) Sales Channels
12.4.2 Rabies Immune Globulin (Human) Distributors
12.5 Rabies Immune Globulin (Human) Customers
13 Market Dynamics
13.1 Rabies Immune Globulin (Human) Industry Trends
13.2 Rabies Immune Globulin (Human) Market Drivers
13.3 Rabies Immune Globulin (Human) Market Challenges
13.4 Rabies Immune Globulin (Human) Market Restraints
14 Key Findings in The Global Rabies Immune Globulin (Human) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Rabies Immune Globulin (Human) Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of HyperRAB S/D
Table 3. Major Manufacturers of KEDRAB
Table 4. Global Rabies Immune Globulin (Human) Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Rabies Immune Globulin (Human) Revenue Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Rabies Immune Globulin (Human) Revenue by Region (2024-2024) & (US$ Million)
Table 7. Global Rabies Immune Globulin (Human) Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Rabies Immune Globulin (Human) Revenue Market Share by Region (2024-2024)
Table 9. Global Rabies Immune Globulin (Human) Revenue Market Share by Region (2024-2034)
Table 10. Global Rabies Immune Globulin (Human) Sales Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 11. Global Rabies Immune Globulin (Human) Sales by Region (2024-2024) & (K Units)
Table 12. Global Rabies Immune Globulin (Human) Sales by Region (2024-2034) & (K Units)
Table 13. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2024-2024)
Table 14. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2024-2034)
Table 15. Global Rabies Immune Globulin (Human) Sales by Manufacturers (2024-2024) & (K Units)
Table 16. Global Rabies Immune Globulin (Human) Sales Share by Manufacturers (2024-2024)
Table 17. Global Rabies Immune Globulin (Human) Revenue by Manufacturers (2024-2024) & (US$ Million)
Table 18. Global Rabies Immune Globulin (Human) Revenue Share by Manufacturers (2024-2024)
Table 19. Global Key Players of Rabies Immune Globulin (Human), Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Rabies Immune Globulin (Human) Price by Manufacturers 2024-2024 (US$/Unit)
Table 21. Global Rabies Immune Globulin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rabies Immune Globulin (Human) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Human) as of 2022)
Table 23. Global Key Manufacturers of Rabies Immune Globulin (Human), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Rabies Immune Globulin (Human), Product Offered and Application
Table 25. Global Key Manufacturers of Rabies Immune Globulin (Human), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rabies Immune Globulin (Human) Sales by Type (2024-2024) & (K Units)
Table 28. Global Rabies Immune Globulin (Human) Sales by Type (2024-2034) & (K Units)
Table 29. Global Rabies Immune Globulin (Human) Sales Share by Type (2024-2024)
Table 30. Global Rabies Immune Globulin (Human) Sales Share by Type (2024-2034)
Table 31. Global Rabies Immune Globulin (Human) Revenue by Type (2024-2024) & (US$ Million)
Table 32. Global Rabies Immune Globulin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Rabies Immune Globulin (Human) Revenue Share by Type (2024-2024)
Table 34. Global Rabies Immune Globulin (Human) Revenue Share by Type (2024-2034)
Table 35. Rabies Immune Globulin (Human) Price by Type (2024-2024) & (US$/Unit)
Table 36. Global Rabies Immune Globulin (Human) Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Rabies Immune Globulin (Human) Sales by Application (2024-2024) & (K Units)
Table 38. Global Rabies Immune Globulin (Human) Sales by Application (2024-2034) & (K Units)
Table 39. Global Rabies Immune Globulin (Human) Sales Share by Application (2024-2024)
Table 40. Global Rabies Immune Globulin (Human) Sales Share by Application (2024-2034)
Table 41. Global Rabies Immune Globulin (Human) Revenue by Application (2024-2024) & (US$ Million)
Table 42. Global Rabies Immune Globulin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Rabies Immune Globulin (Human) Revenue Share by Application (2024-2024)
Table 44. Global Rabies Immune Globulin (Human) Revenue Share by Application (2024-2034)
Table 45. Rabies Immune Globulin (Human) Price by Application (2024-2024) & (US$/Unit)
Table 46. Global Rabies Immune Globulin (Human) Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Rabies Immune Globulin (Human) Sales by Type (2024-2024) & (K Units)
Table 48. US & Canada Rabies Immune Globulin (Human) Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Rabies Immune Globulin (Human) Revenue by Type (2024-2024) & (US$ Million)
Table 50. US & Canada Rabies Immune Globulin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Rabies Immune Globulin (Human) Sales by Application (2024-2024) & (K Units)
Table 52. US & Canada Rabies Immune Globulin (Human) Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Rabies Immune Globulin (Human) Revenue by Application (2024-2024) & (US$ Million)
Table 54. US & Canada Rabies Immune Globulin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Rabies Immune Globulin (Human) Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Rabies Immune Globulin (Human) Revenue by Country (2024-2024) & (US$ Million)
Table 57. US & Canada Rabies Immune Globulin (Human) Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Rabies Immune Globulin (Human) Sales by Country (2024-2024) & (K Units)
Table 59. US & Canada Rabies Immune Globulin (Human) Sales by Country (2024-2034) & (K Units)
Table 60. Europe Rabies Immune Globulin (Human) Sales by Type (2024-2024) & (K Units)
Table 61. Europe Rabies Immune Globulin (Human) Sales by Type (2024-2034) & (K Units)
Table 62. Europe Rabies Immune Globulin (Human) Revenue by Type (2024-2024) & (US$ Million)
Table 63. Europe Rabies Immune Globulin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Rabies Immune Globulin (Human) Sales by Application (2024-2024) & (K Units)
Table 65. Europe Rabies Immune Globulin (Human) Sales by Application (2024-2034) & (K Units)
Table 66. Europe Rabies Immune Globulin (Human) Revenue by Application (2024-2024) & (US$ Million)
Table 67. Europe Rabies Immune Globulin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Rabies Immune Globulin (Human) Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Rabies Immune Globulin (Human) Revenue by Country (2024-2024) & (US$ Million)
Table 70. Europe Rabies Immune Globulin (Human) Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Rabies Immune Globulin (Human) Sales by Country (2024-2024) & (K Units)
Table 72. Europe Rabies Immune Globulin (Human) Sales by Country (2024-2034) & (K Units)
Table 73. China Rabies Immune Globulin (Human) Sales by Type (2024-2024) & (K Units)
Table 74. China Rabies Immune Globulin (Human) Sales by Type (2024-2034) & (K Units)
Table 75. China Rabies Immune Globulin (Human) Revenue by Type (2024-2024) & (US$ Million)
Table 76. China Rabies Immune Globulin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Rabies Immune Globulin (Human) Sales by Application (2024-2024) & (K Units)
Table 78. China Rabies Immune Globulin (Human) Sales by Application (2024-2034) & (K Units)
Table 79. China Rabies Immune Globulin (Human) Revenue by Application (2024-2024) & (US$ Million)
Table 80. China Rabies Immune Globulin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Rabies Immune Globulin (Human) Sales by Type (2024-2024) & (K Units)
Table 82. Asia Rabies Immune Globulin (Human) Sales by Type (2024-2034) & (K Units)
Table 83. Asia Rabies Immune Globulin (Human) Revenue by Type (2024-2024) & (US$ Million)
Table 84. Asia Rabies Immune Globulin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Rabies Immune Globulin (Human) Sales by Application (2024-2024) & (K Units)
Table 86. Asia Rabies Immune Globulin (Human) Sales by Application (2024-2034) & (K Units)
Table 87. Asia Rabies Immune Globulin (Human) Revenue by Application (2024-2024) & (US$ Million)
Table 88. Asia Rabies Immune Globulin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Rabies Immune Globulin (Human) Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Rabies Immune Globulin (Human) Revenue by Region (2024-2024) & (US$ Million)
Table 91. Asia Rabies Immune Globulin (Human) Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Rabies Immune Globulin (Human) Sales by Region (2024-2024) & (K Units)
Table 93. Asia Rabies Immune Globulin (Human) Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Type (2024-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Type (2024-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Application (2024-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Application (2024-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Country (2024-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Country (2024-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales by Country (2024-2034) & (K Units)
Table 107. CSL Behring Company Information
Table 108. CSL Behring Description and Major Businesses
Table 109. CSL Behring Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. CSL Behring Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSL Behring Recent Developments
Table 112. Grifols Company Information
Table 113. Grifols Description and Major Businesses
Table 114. Grifols Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Grifols Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Grifols Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Sanofi Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Kamada Company Information
Table 123. Kamada Description and Major Businesses
Table 124. Kamada Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Kamada Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Kamada Recent Developments
Table 127. Bharat Serum Company Information
Table 128. Bharat Serum Description and Major Businesses
Table 129. Bharat Serum Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Bharat Serum Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Bharat Serum Recent Developments
Table 132. Bio Products Laboratory Company Information
Table 133. Bio Products Laboratory Description and Major Businesses
Table 134. Bio Products Laboratory Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Bio Products Laboratory Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Bio Products Laboratory Recent Developments
Table 137. Shanghai RAAS Company Information
Table 138. Shanghai RAAS Description and Major Businesses
Table 139. Shanghai RAAS Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Shanghai RAAS Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Shanghai RAAS Recent Developments
Table 142. Weiguang Bio Company Information
Table 143. Weiguang Bio Description and Major Businesses
Table 144. Weiguang Bio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Weiguang Bio Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Weiguang Bio Recent Developments
Table 147. Shuanglin Bio Company Information
Table 148. Shuanglin Bio Description and Major Businesses
Table 149. Shuanglin Bio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Shuanglin Bio Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Shuanglin Bio Recent Developments
Table 152. CBPO Company Information
Table 153. CBPO Description and Major Businesses
Table 154. CBPO Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. CBPO Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. CBPO Recent Developments
Table 157. CNBG Company Information
Table 158. CNBG Description and Major Businesses
Table 159. CNBG Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. CNBG Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. CNBG Recent Developments
Table 162. Sichuan Yuanda Shuyang Company Information
Table 163. Sichuan Yuanda Shuyang Description and Major Businesses
Table 164. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Sichuan Yuanda Shuyang Recent Developments
Table 167. Kedrion Biopharma Company Information
Table 168. Kedrion Biopharma Description and Major Businesses
Table 169. Kedrion Biopharma Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 170. Kedrion Biopharma Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Kedrion Biopharma Recent Developments
Table 172. Congruent Pharmachem Company Information
Table 173. Congruent Pharmachem Description and Major Businesses
Table 174. Congruent Pharmachem Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 175. Congruent Pharmachem Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Congruent Pharmachem Recent Developments
Table 177. hualanbio Company Information
Table 178. hualanbio Description and Major Businesses
Table 179. hualanbio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 180. hualanbio Rabies Immune Globulin (Human) Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. hualanbio Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Rabies Immune Globulin (Human) Distributors List
Table 185. Rabies Immune Globulin (Human) Customers List
Table 186. Rabies Immune Globulin (Human) Market Trends
Table 187. Rabies Immune Globulin (Human) Market Drivers
Table 188. Rabies Immune Globulin (Human) Market Challenges
Table 189. Rabies Immune Globulin (Human) Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Rabies Immune Globulin (Human) Product Picture
Figure 2. Global Rabies Immune Globulin (Human) Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Rabies Immune Globulin (Human) Market Share by Type in 2022 & 2034
Figure 4. HyperRAB S/D Product Picture
Figure 5. KEDRAB Product Picture
Figure 6. Global Rabies Immune Globulin (Human) Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Rabies Immune Globulin (Human) Market Share by Application in 2022 & 2034
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Rabies Immune Globulin (Human) Report Years Considered
Figure 11. Global Rabies Immune Globulin (Human) Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 12. Global Rabies Immune Globulin (Human) Revenue 2024-2034 (US$ Million)
Figure 13. Global Rabies Immune Globulin (Human) Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 14. Global Rabies Immune Globulin (Human) Revenue Market Share by Region (2024-2034)
Figure 15. Global Rabies Immune Globulin (Human) Sales 2024-2034 ((K Units)
Figure 16. Global Rabies Immune Globulin (Human) Sales Market Share by Region (2024-2034)
Figure 17. US & Canada Rabies Immune Globulin (Human) Sales YoY (2024-2034) & (K Units)
Figure 18. US & Canada Rabies Immune Globulin (Human) Revenue YoY (2024-2034) & (US$ Million)
Figure 19. Europe Rabies Immune Globulin (Human) Sales YoY (2024-2034) & (K Units)
Figure 20. Europe Rabies Immune Globulin (Human) Revenue YoY (2024-2034) & (US$ Million)
Figure 21. China Rabies Immune Globulin (Human) Sales YoY (2024-2034) & (K Units)
Figure 22. China Rabies Immune Globulin (Human) Revenue YoY (2024-2034) & (US$ Million)
Figure 23. Asia (excluding China) Rabies Immune Globulin (Human) Sales YoY (2024-2034) & (K Units)
Figure 24. Asia (excluding China) Rabies Immune Globulin (Human) Revenue YoY (2024-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales YoY (2024-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue YoY (2024-2034) & (US$ Million)
Figure 27. The Rabies Immune Globulin (Human) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Rabies Immune Globulin (Human) in the World: Market Share by Rabies Immune Globulin (Human) Revenue in 2022
Figure 29. Global Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 30. Global Rabies Immune Globulin (Human) Sales Market Share by Type (2024-2034)
Figure 31. Global Rabies Immune Globulin (Human) Revenue Market Share by Type (2024-2034)
Figure 32. Global Rabies Immune Globulin (Human) Sales Market Share by Application (2024-2034)
Figure 33. Global Rabies Immune Globulin (Human) Revenue Market Share by Application (2024-2034)
Figure 34. US & Canada Rabies Immune Globulin (Human) Sales Market Share by Type (2024-2034)
Figure 35. US & Canada Rabies Immune Globulin (Human) Revenue Market Share by Type (2024-2034)
Figure 36. US & Canada Rabies Immune Globulin (Human) Sales Market Share by Application (2024-2034)
Figure 37. US & Canada Rabies Immune Globulin (Human) Revenue Market Share by Application (2024-2034)
Figure 38. US & Canada Rabies Immune Globulin (Human) Revenue Share by Country (2024-2034)
Figure 39. US & Canada Rabies Immune Globulin (Human) Sales Share by Country (2024-2034)
Figure 40. U.S. Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 41. Canada Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 42. Europe Rabies Immune Globulin (Human) Sales Market Share by Type (2024-2034)
Figure 43. Europe Rabies Immune Globulin (Human) Revenue Market Share by Type (2024-2034)
Figure 44. Europe Rabies Immune Globulin (Human) Sales Market Share by Application (2024-2034)
Figure 45. Europe Rabies Immune Globulin (Human) Revenue Market Share by Application (2024-2034)
Figure 46. Europe Rabies Immune Globulin (Human) Revenue Share by Country (2024-2034)
Figure 47. Europe Rabies Immune Globulin (Human) Sales Share by Country (2024-2034)
Figure 48. Germany Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 49. France Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 50. U.K. Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 51. Italy Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 52. Russia Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 53. China Rabies Immune Globulin (Human) Sales Market Share by Type (2024-2034)
Figure 54. China Rabies Immune Globulin (Human) Revenue Market Share by Type (2024-2034)
Figure 55. China Rabies Immune Globulin (Human) Sales Market Share by Application (2024-2034)
Figure 56. China Rabies Immune Globulin (Human) Revenue Market Share by Application (2024-2034)
Figure 57. Asia Rabies Immune Globulin (Human) Sales Market Share by Type (2024-2034)
Figure 58. Asia Rabies Immune Globulin (Human) Revenue Market Share by Type (2024-2034)
Figure 59. Asia Rabies Immune Globulin (Human) Sales Market Share by Application (2024-2034)
Figure 60. Asia Rabies Immune Globulin (Human) Revenue Market Share by Application (2024-2034)
Figure 61. Asia Rabies Immune Globulin (Human) Revenue Share by Region (2024-2034)
Figure 62. Asia Rabies Immune Globulin (Human) Sales Share by Region (2024-2034)
Figure 63. Japan Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 64. South Korea Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 65. China Taiwan Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 66. Southeast Asia Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 67. India Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales Market Share by Type (2024-2034)
Figure 69. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue Market Share by Type (2024-2034)
Figure 70. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales Market Share by Application (2024-2034)
Figure 71. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue Market Share by Application (2024-2034)
Figure 72. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Revenue Share by Country (2024-2034)
Figure 73. Middle East, Africa and Latin America Rabies Immune Globulin (Human) Sales Share by Country (2024-2034)
Figure 74. Brazil Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 75. Mexico Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 76. Turkey Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 77. Israel Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 78. GCC Countries Rabies Immune Globulin (Human) Revenue (2024-2034) & (US$ Million)
Figure 79. Rabies Immune Globulin (Human) Value Chain
Figure 80. Rabies Immune Globulin (Human) Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed